Anna Ju

407 total citations
14 papers, 323 citations indexed

About

Anna Ju is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Anna Ju has authored 14 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Anna Ju's work include Protein Tyrosine Phosphatases (4 papers), CAR-T cell therapy research (3 papers) and Natural product bioactivities and synthesis (3 papers). Anna Ju is often cited by papers focused on Protein Tyrosine Phosphatases (4 papers), CAR-T cell therapy research (3 papers) and Natural product bioactivities and synthesis (3 papers). Anna Ju collaborates with scholars based in South Korea and United States. Anna Ju's co-authors include Michael N. Margolies, E Haber, Molly Hunter, Sayeon Cho, Young-Chang Cho, Kwonseop Kim, Byoung Chul Park, Jeong‐Hoon Kim, Mihue Jang and Eunice EunKyeong Kim and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biomaterials.

In The Last Decade

Anna Ju

14 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ju South Korea 9 183 108 78 64 28 14 323
Simone L. Popp Germany 8 133 0.7× 212 2.0× 47 0.6× 137 2.1× 17 0.6× 13 407
Christina L. Zuch de Zafra United States 9 143 0.8× 79 0.7× 112 1.4× 104 1.6× 12 0.4× 18 285
Sofía Bruni Argentina 7 130 0.7× 131 1.2× 37 0.5× 193 3.0× 56 2.0× 13 383
Kenshi Yoshida Japan 10 157 0.9× 141 1.3× 24 0.3× 93 1.5× 48 1.7× 20 382
Tulasigeri M. Totiger United States 10 164 0.9× 41 0.4× 26 0.3× 87 1.4× 28 1.0× 22 318
Viviane Ponath Germany 11 150 0.8× 95 0.9× 46 0.6× 114 1.8× 58 2.1× 15 353
Siwen Kang United States 10 132 0.7× 211 2.0× 32 0.4× 123 1.9× 61 2.2× 13 406
Ramkrishna Sadhukhan United States 11 235 1.3× 61 0.6× 25 0.3× 57 0.9× 29 1.0× 18 408
M.E. Forgue-Lafitte France 9 212 1.2× 34 0.3× 34 0.4× 82 1.3× 28 1.0× 13 370
Aric Huang United States 11 183 1.0× 145 1.3× 16 0.2× 52 0.8× 23 0.8× 19 374

Countries citing papers authored by Anna Ju

Since Specialization
Citations

This map shows the geographic impact of Anna Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ju more than expected).

Fields of papers citing papers by Anna Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ju. The network helps show where Anna Ju may publish in the future.

Co-authorship network of co-authors of Anna Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ju. A scholar is included among the top collaborators of Anna Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ju. Anna Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ju, Anna, et al.. (2024). Lymphodepletion in Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: A Focus on Brain Tumors. Brain Tumor Research and Treatment. 12(4). 208–208. 3 indexed citations
2.
Sajib, Md Sanaullah, et al.. (2023). Atezolizumab Induces Necroptosis and Contributes to Hepatotoxicity of Human Hepatocytes. International Journal of Molecular Sciences. 24(14). 11694–11694. 10 indexed citations
3.
Lee, Ji‐Hyun, Ji Woong Kim, Anna Ju, et al.. (2022). A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells. International Journal of Molecular Sciences. 23(13). 6895–6895. 7 indexed citations
4.
Lee, Young Eun, Anna Ju, Jinchul Kim, et al.. (2020). Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment. Journal of Controlled Release. 326. 310–323. 43 indexed citations
5.
Ju, Anna, Sung Won Lee, Young Eun Lee, et al.. (2019). A carrier-free multiplexed gene editing system applicable for suspension cells. Biomaterials. 217. 119298–119298. 28 indexed citations
6.
Seo, Huiyun, Young-Chang Cho, Anna Ju, et al.. (2017). Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways. Scientific Reports. 7(1). 17348–17348. 36 indexed citations
7.
8.
Ju, Anna, Young-Chang Cho, Sung Goo Park, et al.. (2016). Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway. PLoS ONE. 11(10). e0164259–e0164259. 29 indexed citations
9.
10.
Cho, Young-Chang, et al.. (2015). Anti-inflammatory effects of Crataeva nurvala Buch. Ham. are mediated via inactivation of ERK but not NF-κB. Journal of Ethnopharmacology. 162. 140–147. 21 indexed citations
11.
12.
Lee, In‐Seon, Anna Ju, & Sayeon Cho. (2012). Inhibition of DUSP13B Activity by NSC 663284. Bulletin of the Korean Chemical Society. 33(10). 3505–3507. 1 indexed citations
13.
Ju, Anna & Sayeon Cho. (2012). Inhibition of Dual-specificity Phosphatase 22 (DUSP22) by PRL-3 inhibitor I. Bulletin of the Korean Chemical Society. 33(9). 3142–3144. 3 indexed citations
14.
Hunter, Molly, Michael N. Margolies, Anna Ju, & E Haber. (1982). High-affinity monoclonal antibodies to the cardiac glycoside, digoxin.. The Journal of Immunology. 129(3). 1165–1172. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone L. Popp Breakdown of academic impact, for papers by Christina L. Zuch de Zafra Breakdown of academic impact, for papers by Sofía Bruni Breakdown of academic impact, for papers by Kenshi Yoshida Breakdown of academic impact, for papers by Tulasigeri M. Totiger Breakdown of academic impact, for papers by Viviane Ponath Breakdown of academic impact, for papers by Siwen Kang Breakdown of academic impact, for papers by Ramkrishna Sadhukhan Breakdown of academic impact, for papers by M.E. Forgue-Lafitte Breakdown of academic impact, for papers by Aric Huang
Rankless by CCL
2026